Skip to main content

Table 2 Percentage of adverse effects related to the genotypes and alterations in body composition following antiviral treatment.

From: Bioelectrical impedance analysis in clinical practice: implications for hepatitis C therapy BIA and hepatitis C

Adverse effects

HCV genotype 1 (n = 15)

HCV genotype 3 (n = 22)

Cephalgia

8/15 (53.3%) *

8/22 (36.3%)

Fatigue

13/15 (86.6%) *

12/22 (54.5%)

Flu-like symptoms

10/15 (66.6%)

18/22 (81.8%) *

  1. Symptoms of fatigue and cephalgia were more evident in patients with genotype 1 whereas flu-like symptoms were more present in patients with genotype 3 following antiviral treatment (* p < 0.05).